Skip to main navigation Skip to search Skip to main content

Project Details

Description

A Long-Term Open-Label Treatment and Extension Study of UX003 rhGUS Enzyme Replacement Therapy in Subjects with MPS 7
StatusFinished
Effective start/end date2/16/16 → 10/31/19

Funding

  • ULTRAGENYX PHARMACEUTICAL INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.